Tenon Medical Closes $4.3M Private Placement

The medical device company raised funds to continue transforming care for patients with sacro-pelvic disorders.

Mar. 12, 2026 at 12:49pm

Got story updates? Submit your updates here. ›

Tenon Medical, Inc., a company focused on treating certain sacro-pelvic disorders, announced the closing of a $4.3 million private placement of senior convertible notes. The funds will be used to support the company's ongoing efforts to transform care for patients suffering from these conditions.

Why it matters

Tenon Medical is a publicly traded medical device company working to address an underserved area of healthcare. The successful private placement will provide the company with additional capital to continue developing and commercializing its innovative solutions for sacro-pelvic disorders, which can significantly impact patient quality of life.

The details

The private placement consisted of senior convertible notes. Tenon will use the $4.3 million in gross proceeds to support its research, development, and commercialization activities as it works to transform care for patients with certain sacro-pelvic disorders.

  • Tenon Medical announced the closing of the private placement on March 12, 2026.

The players

Tenon Medical, Inc.

A publicly traded medical device company focused on transforming care for patients suffering with certain sacro-pelvic disorders.

Got photos? Submit your photos here. ›

The takeaway

Tenon Medical's successful private placement highlights investor interest in innovative medical solutions targeting underserved patient populations. The additional capital will allow the company to continue advancing its efforts to improve care and outcomes for those suffering from sacro-pelvic disorders.